New insider activity at MoonLake Immunotherapeutics ( (MLTX) ) has taken place on October 1, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Former 10% owner Bihua Chen has made a significant move by selling 6,499,978 shares of MoonLake Immunotherapeutics stock, amounting to a total transaction value of $46,868,184.
Recent Updates on MLTX stock
In the past 24 hours, MoonLake Immunotherapeutics experienced significant price target downgrades from several analysts, primarily due to disappointing results from the Phase 3 VELA program for their drug sonelokimab in treating hidradenitis suppurativa. Goldman Sachs, Needham, Guggenheim, Citi, and Wolfe Research all lowered their price targets, citing weakened commercial potential, significant regulatory risks, and financial challenges. The mixed topline results, particularly the failure to meet the primary endpoint due to a higher placebo effect, have cast doubt on the drug’s future, prompting concerns about the need for additional trials. Despite these setbacks, some analysts noted the drug’s efficacy was in line with competitors in other trials, and the company is pursuing other indications in a multibillion market.
Spark’s Take on MLTX Stock
According to Spark, TipRanks’ AI Analyst, MLTX is a Neutral.
MoonLake Immunotherapeutics presents a high-risk, high-reward scenario typical for early-stage biotech firms. The strong balance sheet and recent financing provide a solid financial foundation, but the lack of revenue and operational losses weigh heavily on the score. Technical indicators are mixed, and the negative valuation metrics reflect the developmental nature of the company. The significant financing event is a positive catalyst, enhancing the company’s ability to advance its pipeline.
To see Spark’s full report on MLTX stock, click here.
More about MoonLake Immunotherapeutics
YTD Price Performance: -86.62%
Average Trading Volume: 2,421,059
Technical Sentiment Signal: Sell
Current Market Cap: $401.1M